Skip to content

Yann Mazabraud, EVP, Head of International at Rhythm Pharmaceuticals, sold RYTM on Aug 12, 2026

Data as of Oct 16

▼ SELL$413K3,605 shares at $114.70Yann Mazabraud EVP, Head of InternationalRYTM Rhythm Pharmaceuticals, Inc.
Watch RYTM
Traded
Aug 12, 2026
Disclosed
Aug 14, 2026
Filed
2 days after the trade

Form 4s are due within two business days.

Official filing (SEC Form 4) ↗

The price around the disclosure

Yann Mazabraud, EVP, Head of International at Rhythm Pharmaceuticals, sold RYTM on Aug 12, 2026TRADEDDISCLOSED
RYTMSimilar stocks (XLV — its sector index fund), rebased to RYTM's price on the disclosure day
RYTM since disclosure
−25.4%
after the sale
Similar stocks (XLV) since disclosure
+5.6%
XLV — its sector index fund

Change in closing price from Aug 14, 2026 (the first trading day on or after disclosure) to Oct 16, 2026. Dividends excluded. Not a return anyone earned.

Our take

None of our tested rules fired on this trade.

Other trades in the same filing

  1. ▼ SELLYann Mazabraud EVP, Head of InternationalRYTM Rhythm Pharmaceuticals, Inc.$2.1Mdisclosed Aug 14 · filed 2 days after the trade
  2. ▼ SELLYann Mazabraud EVP, Head of InternationalRYTM Rhythm Pharmaceuticals, Inc.$1.7Mdisclosed Aug 14 · filed 2 days after the trade
  3. ▼ SELLYann Mazabraud EVP, Head of InternationalRYTM Rhythm Pharmaceuticals, Inc.$113Kdisclosed Aug 14 · filed 2 days after the trade
  4. ▼ SELLYann Mazabraud EVP, Head of InternationalRYTM Rhythm Pharmaceuticals, Inc.$2Mdisclosed Aug 14 · filed 2 days after the trade
  5. ▼ SELLYann Mazabraud EVP, Head of InternationalRYTM Rhythm Pharmaceuticals, Inc.$257Kdisclosed Aug 14 · filed 2 days after the trade

See every trade on RYTM →